Emerging research from Australia has unveiled troubling findings regarding the health implications of vaping, suggesting a significant association between e-cigarette use and the risk of developing lung and oral cancers. A review conducted by scientists at the University of New South Wales highlights early warning signs within the body, including DNA damage and inflammation, urging regulators to take immediate action rather than waiting for conclusive long-term data.
Vaping and Cancer: The Evidence Unfolds
The comprehensive analysis reviewed a range of studies conducted between 2017 and 2025, encompassing laboratory experiments, animal research, and human case reports. According to the findings published in the journal *Carcinogenesis*, vaping is not merely a safer alternative to smoking; it is linked to biological alterations that can precede cancer development.
Adjunct Professor Bernard Stewart, a co-author of the study, stated, “There is no doubt that the cells and tissues of the oral cavity, the mouth and the lungs are altered by inhalation from e-cigarettes.” This assertion is critical, given that vaping was introduced only in the early 2000s, leaving a gap in extensive long-term studies needed to establish definitive cancer risks.
Early Biological Changes Indicating Risk
While the review did not quantify the exact incidence of cancer attributable to vaping, it shed light on the pre-carcinogenic changes occurring in those who use e-cigarettes. Notably, dentists have reported cases of oral cancer in individuals who exclusively vaped, with no prior history of smoking. Furthermore, animal studies indicated that mice exposed to e-cigarette vapour developed lung tumours at higher rates than their unexposed counterparts.
This evidence points to the pressing need for public health authorities to heed these initial warning signs. Lead author Associate Professor Freddy Sitas emphasised that it took a century for the US Surgeon General to officially recognise smoking as a cause of lung cancer. He cautioned against dismissing vaping’s potential risks, as history may repeat itself if emerging evidence continues to be overlooked.
Regulatory Action and Public Safety
Public health experts are calling for immediate regulatory measures to safeguard vulnerable populations, particularly young people, from potential harm. Calvin Cochran, a research fellow at the University of Otago, noted that nearly 8,000 studies were evaluated to reach the current conclusions, emphasising the importance of taking these findings seriously. He argued that policymakers must not wait for an unequivocal moment of clarity regarding vaping’s risks.
While some experts maintain that vaping does not carry the same degree of risk as smoking due to the absence of combustion products, others, like Professor Stephen Duffy from Queen Mary University London, caution against downplaying the risks associated with e-cigarettes. Stewart insisted that vaping should be studied for its own potential health impacts, rather than merely as a comparative risk to smoking.
A Call for Awareness and Prevention
Professor Becky Freeman from the University of Sydney highlighted the critical implications of the study, stating, “This study is the first to assert that there is likely an increased cancer risk for people who vape, compared to people who do not vape.” This revelation is particularly concerning for young individuals who have never smoked, reinforcing the notion that vaping is not a safe substitute for smoking.
In light of these findings, Australian regulations that restrict vaping products to pharmacy-only access for those seeking to quit smoking are seen as a necessary step. This balanced approach aims to prevent youth from accessing vaping while providing support for those aiming to quit traditional cigarettes.
Why it Matters
The implications of this research extend far beyond academic interest; they pose significant questions about public health policy and the future of tobacco control. As vaping becomes increasingly popular, understanding its potential health risks is paramount. Immediate and informed action by regulators is essential to protect public health, particularly among younger populations who may view vaping as a harmless alternative. The findings serve as a reminder that vigilance and proactive measures are crucial in the ongoing battle against tobacco-related diseases.
